NICE approves three quarters of CDF group 1 drugs
More than 75 percent of treatments in the Cancer Drugs Fund (CDF) which have been reappraised by NICE have received positive recommendations for routine NHS use.
Read More
Search Results for: Dr Andy Round
Denying drugs on age grounds to be illegal: govt
Denying elderly NHS patients drugs and other treatments purely because of their age is to be made illegal from October, Ministers have announced.
Read More
Milner Therapeutics to establish new genomics laboratory for drug discovery
The new state-of-the-art facility is set to be operational in early 2024
Read More
Vitestro raises vital funding for autonomous blood drawing device
Company raises €12m in financing with a view to entering to the European market
Read More
Driving change
Recognising the role of communications in building a sustainable business
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
